Cargando…
Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
BACKGROUND: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625604/ https://www.ncbi.nlm.nih.gov/pubmed/26514413 http://dx.doi.org/10.1186/s13049-015-0165-4 |
_version_ | 1782398004352778240 |
---|---|
author | Ponschab, Martin Voelckel, Wolfgang Pavelka, Michaela Schlimp, Christoph J. Schöchl, Herbert |
author_facet | Ponschab, Martin Voelckel, Wolfgang Pavelka, Michaela Schlimp, Christoph J. Schöchl, Herbert |
author_sort | Ponschab, Martin |
collection | PubMed |
description | BACKGROUND: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC has not been adequately investigated. METHODS: In this retrospective observational study, changes to ROTEM parameters, induced by three different therapeutic interventions, were investigated: patients receiving FC only (FC-group); patients treated with FC and PCC (FC + PCC-group) and patients treated with PCC only (PCC-group). RESULTS: The study population comprised 96 patients who were predominately male (69 [71.9 %]), median age was 45.0 (26.3–60.0) years, and the median injury severity score was 34.0 (25.0–44.5). Administration of FC resulted in a significant reduction of the clotting time (CT) in both the EXTEM and FIBTEM assays but had no effect on INTEM CT. Clot amplitude (CA) increased significantly in the FIBTEM assay but remained unchanged in the EXTEM and INTEM assays. The combined administration of FC and PCC increased FIBTEM maximum clot firmness (MCF) and normalized EXTEM CT but did not change either INTEM or FIBTEM CT. Following PCC therapy, EXTEM and FIBTEM CT normalized; CA at 10 min after CT measurements decreased significantly in EXTEM, INTEM and FIBTEM. CONCLUSIONS: Administration of FC alone or in combination with PCC resulted in a significant improvement of fibrin polymerisation as measured by an increase in FIBTEM MCF. CT is dependent not only on thrombin generation but also on the availability of substrate (fibrinogen). Accelerated fibrin polymerisation rate results in earlier clot formation and consequently shorter CT. PCC administration normalised EXTEM CT below the upper threshold of 80 s. This study was performed at the AUVA Trauma Centre Salzburg, Salzburg, Austria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13049-015-0165-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4625604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46256042015-10-30 Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma Ponschab, Martin Voelckel, Wolfgang Pavelka, Michaela Schlimp, Christoph J. Schöchl, Herbert Scand J Trauma Resusc Emerg Med Original Research BACKGROUND: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC has not been adequately investigated. METHODS: In this retrospective observational study, changes to ROTEM parameters, induced by three different therapeutic interventions, were investigated: patients receiving FC only (FC-group); patients treated with FC and PCC (FC + PCC-group) and patients treated with PCC only (PCC-group). RESULTS: The study population comprised 96 patients who were predominately male (69 [71.9 %]), median age was 45.0 (26.3–60.0) years, and the median injury severity score was 34.0 (25.0–44.5). Administration of FC resulted in a significant reduction of the clotting time (CT) in both the EXTEM and FIBTEM assays but had no effect on INTEM CT. Clot amplitude (CA) increased significantly in the FIBTEM assay but remained unchanged in the EXTEM and INTEM assays. The combined administration of FC and PCC increased FIBTEM maximum clot firmness (MCF) and normalized EXTEM CT but did not change either INTEM or FIBTEM CT. Following PCC therapy, EXTEM and FIBTEM CT normalized; CA at 10 min after CT measurements decreased significantly in EXTEM, INTEM and FIBTEM. CONCLUSIONS: Administration of FC alone or in combination with PCC resulted in a significant improvement of fibrin polymerisation as measured by an increase in FIBTEM MCF. CT is dependent not only on thrombin generation but also on the availability of substrate (fibrinogen). Accelerated fibrin polymerisation rate results in earlier clot formation and consequently shorter CT. PCC administration normalised EXTEM CT below the upper threshold of 80 s. This study was performed at the AUVA Trauma Centre Salzburg, Salzburg, Austria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13049-015-0165-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-29 /pmc/articles/PMC4625604/ /pubmed/26514413 http://dx.doi.org/10.1186/s13049-015-0165-4 Text en © Ponschab et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Research Ponschab, Martin Voelckel, Wolfgang Pavelka, Michaela Schlimp, Christoph J. Schöchl, Herbert Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma |
title | Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma |
title_full | Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma |
title_fullStr | Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma |
title_full_unstemmed | Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma |
title_short | Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma |
title_sort | effect of coagulation factor concentrate administration on rotem® parameters in major trauma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625604/ https://www.ncbi.nlm.nih.gov/pubmed/26514413 http://dx.doi.org/10.1186/s13049-015-0165-4 |
work_keys_str_mv | AT ponschabmartin effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma AT voelckelwolfgang effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma AT pavelkamichaela effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma AT schlimpchristophj effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma AT schochlherbert effectofcoagulationfactorconcentrateadministrationonrotemparametersinmajortrauma |